Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
about
The hypocretin/orexin systemPersistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disordersClinical and biochemical manifestations of depression: relation to the neurobiology of stressHypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy.Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?Regulation of corticosteroid receptor gene expression in depression and antidepressant actionThe pathophysiology of chronic fatigue syndrome: confirmations, contradictions, and conjectures.Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder.Role of cardiovascular reactivity to mental stress in predicting future hypertension.Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.The neuroimmune-endocrine axis: pathophysiological implications for the central nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics.Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells.Benzodiazepines and anterior pituitary function.Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implicationsThe Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care PhysiciansStructural analysis of the regulatory region of the human corticotropin releasing hormone gene.Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptorsAnxiety and cardiovascular risk: Review of Epidemiological and Clinical EvidenceCorticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiencyStructural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic disorders related to depression.Relation between psychological strain and carotid atherosclerosis in a general populationImportance of studying the contributions of early adverse experience to neurobiological findings in depression.Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depressionLong-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.Endocrine disturbances in depression.Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activityOrganization and Integration of the Endocrine System.Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions.Psychiatric Characteristics of the Cardiac Outpatients with Chest Pain.Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment.Psychoendocrinological aspects of affective disorders.Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response
P2860
Q24537243-351AF064-5563-4113-82F4-A7C7C916A7F5Q24567741-A52CA1A5-39E9-4997-8041-ECD45995D599Q26824899-352EC3F6-C2D1-45AD-8A3C-631A2D9A6831Q30250270-9A6FD89B-CF38-4DEC-A040-DF68BD2ABC7FQ30454280-38BC3048-6B0D-499C-A6F8-ACFBAFD6B913Q30454937-63563099-2505-4A36-92B7-0C692BBBD935Q30498987-47AD7DA1-B612-4EF9-907A-91A1A444232BQ30834887-FE8393A9-6E25-4DBC-9688-68DFEE40C4E2Q31142879-8EEA5A70-517E-4A5E-A42E-9CD80B31EEA8Q33844260-DF1DA24F-4A3D-432A-AC84-096D3E851E4BQ33880940-B71ED230-D850-42FD-B3BB-B1F67AE54EBFQ34044609-632A3892-D5A4-4240-8EF6-C4552D54E4DCQ34138015-2C4C4D71-7C7E-42BF-9BBE-A774FAB33CE1Q34144521-DDE8247B-E478-4A3E-AF67-7D8D3C0222D3Q34150270-1426E8ED-9E71-4702-8816-AC2AC7C7E23EQ34185892-BD4784C1-FD0D-4979-831E-FB40A907D593Q34304937-47B0D4EF-D07C-4331-BA93-8CF474EB2938Q34343352-A7AEACD7-56BF-4EA1-929E-12E5FA9DFEC0Q34348095-8F9CE1D0-EF3B-47F5-A8D9-0E45E9420C88Q34555737-E942EC4A-D723-4BD2-A2E5-824005F5D500Q34561818-EFDDA908-AD2C-4E46-9A05-DC4188B51BD0Q34580335-D1786FEA-F248-4223-97B2-A4F553918D3FQ34740438-54D38A3A-ED5C-4ED8-A526-73F6CD87ED7FQ34760816-20FA03E9-60EC-4036-A6C2-D0073CE7644DQ35043823-FDCBF61F-65C8-4CA1-92DB-4B1514A199F3Q35147229-E5748163-9CD9-47F4-9E89-27DAE350F320Q35158831-CB40517E-5AC5-46D3-894F-DFDC23373581Q35236796-89A0589B-23C8-44A6-A288-EBB8B4453B2EQ35583963-02015C72-05F8-4C0E-A62F-96C8C52B76CBQ35701124-F2C67698-AD58-45A0-8280-436E5577BBB5Q35790395-B3B50720-6209-49D0-BED6-C89C743D5E44Q35819190-A2BAF73E-5281-47D1-91F7-7D613810569BQ36091591-EC7DA459-A796-4EC3-9811-67A90A3F06F8Q36132836-06B65891-A5AE-4DE9-9365-1DF386D76FA9Q36248099-88AF77E2-3D9A-4D74-9B78-773E145405D1Q36553056-B298A622-5251-42B2-ACC5-C65A775F8851Q36723474-3FC69957-12BE-47EF-98F5-B150275F3E37Q36894215-35FE5FC5-A691-41A5-B332-9779E410FA93Q37042366-0409A40B-6832-4D9A-9CAE-D06345DCD341Q37114996-A12C7521-905C-4ACC-BCDE-87AC1DE03E20
P2860
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Responses to corticotropin-rel ...... c and diagnostic implications.
@en
Responses to corticotropin-rel ...... c and diagnostic implications.
@nl
type
label
Responses to corticotropin-rel ...... c and diagnostic implications.
@en
Responses to corticotropin-rel ...... c and diagnostic implications.
@nl
prefLabel
Responses to corticotropin-rel ...... c and diagnostic implications.
@en
Responses to corticotropin-rel ...... c and diagnostic implications.
@nl
P2093
P1476
Responses to corticotropin-rel ...... c and diagnostic implications.
@en
P2093
Calabrese JR
Gallucci W
Kellner CH
Loriaux DL
P304
P356
10.1056/NEJM198605223142101
P407
P577
1986-05-01T00:00:00Z